SER

Serina Therapeutics, Inc.

3.03

USD

SER Earnings Reports

Positive Surprise Ratio

SER beat 2 of 3 last estimates.

67%

Next Report

Next Week

Date of Next Report

Mar 30, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.46

Implied change from Q4 26 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

Serina Therapeutics, Inc. earnings per share and revenue

On Mar 23, 2026, SER reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.44 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.

Looking ahead to Q4 25, -- analysts forecast an EPS of -0.46 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Dyadic International, Inc.

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.06

Surprise

-30.72%

TELA Bio, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.18

Actual

-$0.16

Surprise

+14.12%

BioCardia, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.17

Actual

-$0.06

Surprise

+65.40%

Celcuity Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$1.06

Actual

-$0.97

Surprise

+8.72%

Precigen, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.01

Surprise

+88.24%

Absci Corporation Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.23

Surprise

-16.04%

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

LENZ Therapeutics, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.99

Actual

-$1.15

Surprise

-17.10%

Fennec Pharmaceuticals Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

$0.03

Actual

-$0.11

Surprise

-408.12%

Equillium, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.04

Surprise

+35.28%

FAQ

What were Serina Therapeutics, Inc.'s earnings and revenue for the latest quarter Q4 2026?

For Q4 2026, Serina Therapeutics, Inc. reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.

How did the market react to Serina Therapeutics, Inc.'s Q4 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Serina Therapeutics, Inc. expected to report next?

The next earning report is scheduled for Mar 30, 2026.

What are the forecasts for Serina Therapeutics, Inc.'s next earnings report?

Based on -- analysts, Serina Therapeutics, Inc. is expected to report EPS of -$0.46 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.